NachrichtenKI-unterstützt
Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification
Marksans Pharma's Goa facility receives EIR from USFDA, inspection classified as VAI.
Von Mrudula Kulkarni
Redaktionsleiter – Pharma Now
21. Aug. 2024Updated Jun 26, 2025 · 2 Min. Lesezeit
KI-unterstützte Berichterstattung
Reviewed by Mrudula Kulkarni, Redaktionsleiter – Pharma Now
For its production site in Verna, Goa, Marksans Pharma said that the USFDA had issued an Establishment Inspection Report (EIR), which it has now successfully closed. According to USFDA findings, this facility's inspection categorisation is Voluntary Action Indicated (VAI).
ThemenNachrichten
Written by
Mrudula Kulkarni
Redaktionsleiter – Pharma Now
My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
Mehr aus Pharma News
Alle Beiträge →
Nachrichten
Ab Science überarbeitet Studienzeitpläne nach drei GCP-Inspektionen
Simantini Singh Deo · 29. Sept. 2026
Nachrichten
Novo Nordisk unterzeichnet einen $2,6B-Deal mit Hengrui für orales GLP-1
Simantini Singh Deo · 29. Sept. 2026
Nachrichten
Teva erhält FDA-Zulassung für DEGEVMA und vervollständigt Denosumab-Portfolio
Simantini Singh Deo · 29. Sept. 2026
Discussion